Every time a Brazilian walks into a pharmacy, there is a good chance Profarma put the medicine on the shelf. The company is the country's second-largest pharmaceutical distributor — and, after a landmark acquisition in 2026, it is back in the high-growth world of specialty drugs too. Full nameProfarma Distribuidora de Produtos Farmacêuticos S.A. Ticker / exchangePFRM3 — B3 (São Paulo), Novo Mercado HeadquartersRio de Janeiro, RJ, Brazil SectorHealthcare — Medical Distribution Employees~7,300 (group; not disclosed in RT) Market value (market cap)R$802m (US$156 mn) (~$156m) Yearly sales (revenue, FY2025)R$11.45bn (US$2.2 …
Profarma Distribuidora de Produtos Farmacêuticos S.A
·
June 22, 2026
·
5 min read
Company Intelligence — Institutional Access
This dossier is part of our Company Intelligence database.
Full profiles, exchange dossiers and the regional intelligence briefs are available to institutional subscribers. Professional from US$490/year, Corporate US$1,450, Institutional US$3,900.
See institutional access →Already a subscriber? Log in.
Part of LatAm Company Intelligence
This company profile belongs to The Rio Times' research on every listed company and exchange in Latin America and the Caribbean. Browse the full intelligence hub →
Read More from The Rio Times
The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →